JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5226
WisdomTree Dynamic International Equity Fund
DDWM
$1.43B
| $216K | ﹤0.01% |
6,296
-689
| -10% | -$24K |
2022 Q4
8 quarters
|
|
5227
Sagimet Biosciences
SGMT
$568M
| $216K | ﹤0.01% |
48,064
-23,953
| -33% | -$121K |
2023 Q3
5 quarters
|
|
5228
Invesco Mortgage Capital
IVR
$622M
| $216K | ﹤0.01% |
26,841
-115,133
| -81% | -$966K |
2013 Q2
46 quarters
|
|
5229
John Hancock Multifactor Developed International ETF
JHMD
$956M
| $216K | ﹤0.01% |
6,722
+4,622
| +220% | +$155K |
2023 Q3
5 quarters
|
|
5230
RCI Hospitality Holdings
RICK
$203M
| $215K | ﹤0.01% |
3,749
+1
| +0% | +$49 |
2016 Q1
35 quarters
|
|
5231
Franklin Emerging Market Core Dividend Tilt Index ETF
DIEM
$95.2M
| $214K | ﹤0.01% |
8,062
+1,546
| +24% | +$42.5K |
2023 Q2
6 quarters
|
|
|
IBHE
5232
DELISTED
iShares iBonds 2025 Term High Yield and Income ETF
IBHE
| $214K | ﹤0.01% |
+9,212
| New | +$214K |
2024 Q4
0 quarters
|
|
5233
Innovator US Equity Power Buffer ETF April
PAPR
$964M
| $213K | ﹤0.01% |
5,804
+5,667
| +4,136% | +$207K |
2022 Q4
8 quarters
|
|
5234
CALL
Teladoc Health
TDOC
$1B
| $213K | ﹤0.01% |
23,400
+19,800
| +550% | +$191K |
2024 Q2
2 quarters
|
|
|
PPTA
5235
Perpetua Resources
PPTA
$2.55B
| $212K | ﹤0.01% |
19,861
-37,297
| -65% | -$383K |
2023 Q2
6 quarters
|
|
|
UFOX
5236
Defiance Space and Connective Tech ETF
UFOX
$912M
| $211K | ﹤0.01% |
4,435
+58
| +1% | +$2.67K |
2020 Q4
16 quarters
|
|
5237
First Trust US Equity Opportunities ETF
FPX
$1.47B
| $211K | ﹤0.01% |
1,761
+1,317
| +297% | +$158K |
2022 Q4
8 quarters
|
|
5238
Direxion Daily Financial Bull 3x ETF
FAS
$1.85B
| $210K | ﹤0.01% |
1,394
-81
| -5% | -$12.5K |
2024 Q3
1 quarter
|
|
5239
Amylyx Pharmaceuticals
AMLX
$3.55B
| $210K | ﹤0.01% |
55,606
-84,953
| -60% | -$400K |
2022 Q1
11 quarters
|
|
5240
iShares Global Consumer Staples ETF
KXI
$1.1B
| $209K | ﹤0.01% |
3,466
-634
| -15% | -$40K |
2020 Q1
19 quarters
|
|
5241
Sportsman's Warehouse
SPWH
$44.2M
| $209K | ﹤0.01% |
78,186
+76,751
| +5,349% | +$192K |
2017 Q3
29 quarters
|
|
5242
Achieve Life Sciences
ACHV
$745M
| $209K | ﹤0.01% |
59,265
+44,311
| +296% | +$201K |
2024 Q2
2 quarters
|
|
5243
Cato Corp
CATO
$47.8M
| $208K | ﹤0.01% |
53,282
-32,339
| -38% | -$158K |
2013 Q2
46 quarters
|
|
5244
iShares ESG Screened S&P 500 ETF
XVV
$685M
| $207K | ﹤0.01% |
4,570
-1,584
| -26% | -$72K |
2024 Q2
2 quarters
|
|
5245
Forafric Global
AFRI
$303M
| $207K | ﹤0.01% |
20,185
+11,090
| +122% | +$115K |
2023 Q2
6 quarters
|
|
5246
Gogoro
GGR
$64.2M
| $206K | ﹤0.01% |
20,657
-7,509
| -27% | -$81K |
2022 Q3
9 quarters
|
|
5247
Lionsgate Studios
LION
$3.32B
| $206K | ﹤0.01% |
+27,058
| New | +$188K |
2024 Q4
0 quarters
|
|
5248
Invesco BulletShares 2027 High Yield Corporate Bond ETF
BSJR
$910M
| $206K | ﹤0.01% |
+9,179
| New | +$207K |
2024 Q4
0 quarters
|
|
5249
iShares US Oil Equipment & Services ETF
IEZ
$347M
| $205K | ﹤0.01% |
10,352
-10
| -0.1% | -$206 |
2013 Q2
46 quarters
|
|
5250
Dine Brands
DIN
$379M
| $204K | ﹤0.01% |
6,787
-88,612
| -93% | -$2.85M |
2013 Q2
46 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.